BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25343701)

  • 1. Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture.
    Shields CL; Kaliki S; Crabtree GS; Peshtani A; Morton S; Anand RA; Coco G; Shields JA
    Cornea; 2015 Jan; 34(1):42-8. PubMed ID: 25343701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iris melanoma: risk factors for metastasis in 169 consecutive patients.
    Shields CL; Shields JA; Materin M; Gershenbaum E; Singh AD; Smith A
    Ophthalmology; 2001 Jan; 108(1):172-8. PubMed ID: 11150284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
    Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
    Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Anterior Retinoblastoma with Globe Salvage and Visual Preservation in 3 Consecutive Cases.
    Shields CL; Lally SE; Manjandavida FP; Leahey AM; Shields JA
    Ophthalmology; 2016 Feb; 123(2):378-384. PubMed ID: 26522706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients.
    Shah SU; Mashayekhi A; Shields CL; Walia HS; Hubbard GB; Zhang J; Shields JA
    Ophthalmology; 2014 Jan; 121(1):352-357. PubMed ID: 23988200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque Radiotherapy for Medulloepithelioma in 6 Cases From a Single Center.
    Ang SM; Dalvin LA; Emrich J; Komarnicky L; Shields JA; Shields CL
    Asia Pac J Ophthalmol (Phila); 2019; 8(1):30-35. PubMed ID: 30375203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iris involvement by lymphoma: a review of 13 cases.
    Mashayekhi A; Shields CL; Shields JA
    Clin Exp Ophthalmol; 2013; 41(1):19-26. PubMed ID: 22594613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression Patterns of Iris Melanoma after Palladium-103 (
    Chaugule SS; Finger PT
    Ophthalmology; 2017 Jul; 124(7):1023-1030. PubMed ID: 28377036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton beam radiotherapy of diffuse iris melanoma in 54 patients.
    Willerding GD; Cordini D; Hackl C; Karle B; Lakotka N; Foerster MH; Bechrakis NN; Heufelder J; Moser L; Joussen AM
    Br J Ophthalmol; 2015 Jun; 99(6):812-6. PubMed ID: 25505288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iris melanoma: features and prognosis in 317 children and adults.
    Shields CL; Kaliki S; Shah SU; Luo W; Furuta M; Shields JA
    J AAPOS; 2012 Feb; 16(1):10-6. PubMed ID: 22370659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture.
    Shields CL; Khoo CTL; Mazloumi M; Mashayekhi A; Shields JA
    Ophthalmol Retina; 2020 Mar; 4(3):310-319. PubMed ID: 31953111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic tumors to the iris in 40 patients.
    Shields JA; Shields CL; Kiratli H; de Potter P
    Am J Ophthalmol; 1995 Apr; 119(4):422-30. PubMed ID: 7709967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse iris melanoma: a report of 25 cases.
    Demirci H; Shields CL; Shields JA; Eagle RC; Honavar SG
    Ophthalmology; 2002 Aug; 109(8):1553-60. PubMed ID: 12153810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
    Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
    Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with elevated intraocular pressure in eyes with iris melanoma.
    Shields CL; Materin MA; Shields JA; Gershenbaum E; Singh AD; Smith A
    Br J Ophthalmol; 2001 Jun; 85(6):666-9. PubMed ID: 11371484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma.
    Xu TT; Pulido JS; Deufel CL; Corbin KS; Petersen IA; Dalvin LA
    Eye (Lond); 2021 Oct; 35(10):2754-2762. PubMed ID: 33235338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iris metastasis as the initial presentation of metastatic esophageal cancer diagnosed by fine needle aspiration biopsy: A case report.
    Ozawa H; Usui Y; Takano Y; Horiuchi N; Kuribayashi T; Kurihara T; Smith LEH; Tsubota K; Tomita Y
    Medicine (Baltimore); 2021 Jun; 100(22):e26232. PubMed ID: 34087906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.